Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Action starts phase II trial with AP-214 for organ failure associated with surgery

July 1, 2008

FDA Advisory Committee recommends approval of tolvaptan

June 26, 2008

Nymox presents new data for NX-1207 in benign prostatic hyperplasia

June 26, 2008

FDA approves Avodart in combination with tamsulosin for enlarged prostate

June 23, 2008

Nymox commences phase III NX-1207 program

June 11, 2008

Recent Roche patent reports new therapeutic agents for urological disorders

June 9, 2008

Nabi receives a USD 2.5 million milestone payment from Fresenius for CARE-2 study

June 6, 2008

Altus reports top-line results from ALTU-237 phase I clinical trial

June 4, 2008

Nymox reports significant improvement in BPH symptoms after NX-1207 treatment

May 30, 2008

EMEA notified by sanofi-aventis of its withdrawal of the MAA for Aquilda

May 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...